Stockreport

Eidos +15.4% as BridgeBio floats takeout at 20% premium [Seeking Alpha]

EIDOS THERAPEUTICS  (EIDX) 
Last eidos therapeutics earnings: 10/31 04:30 pm Check Earnings Report
PDF Eidos +15.4% as BridgeBio floats takeout at 20% premium Eidos Therapeutics (NASDAQ: EIDX up 15.4% filing BBIO The offer is for a fixed exchange ratio of 1.3 BridgeBio sh [Read more]